Youssef Bennani

Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis

Operates as a biopharmaceutical company which develops and sells drug development technologies

Operates as a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of refractory chronic disease

Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies

CTI Capital Inc. offers debt and equity trading, portfolio management, research, retail brokerage and investment banking services. They specialize in initial public offerings and new issues, private placements, reverse takeovers, capital pool companies, mergers and acquisitions and exchange sponsorships for emerging growth-oriented companies. The firm's equity research focuses on continuous global monitoring of the Canadian stock market. Their strategies are based on the evaluation of economic, financial and technical data. The firm employs market call systems that are based on fundamental and technical factors. Their fixed-income research seeks to identify the optimal strategy for the term, duration and tactical opportunities between different sectors of the market. The CTI Sciences Fund is a venture capital fund that invests primarily in companies located in Quebec and Canada. The Fund focuses on investments in biotechnological or biopharmaceutical products and medical devices. The financial partners of this private venture are the Caisse de dépôt et placement du Québec, Fonds de solidarité FTQ, FIER Partenaires S.E.C. and the Régime des rentes du Mouvement Desjardins.

Functions as a College/University

Functions as a College/University

Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products

Promotes governance and develops leadership skills